Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.
A legfontosabb adatok
- Ki végzi
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Hol
- Beijing (Kína)A helyszín megnézése
- Azonosító
- Állapot
- Toboroz
- Résztvevők
- 73 fő, tervezett
- Kezdés
- 2021. nov. 12.
- Várható befejezés
- 2028. dec. 31.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Multi-Branched Thoracoabdominal Stent Graft System
- A regiszteradat frissítve
- 2025. június 22.
Ki vehet részt
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.
The trial is looking for adults with a thoracoabdominal aortic aneurysm (a bulge in the main artery across chest and belly). It tests a multi-branched stent graft placed inside the artery.
- Életkor
- 18 to 80 years
- Nem
- All sexes
- A betegség stádiuma
- Thoracoabdominal aortic aneurysm wider than 50mm, or growing more than 5mm in 6 months or more than 10mm in 1 year. The artery shape and size must fit the device, and the arteries in the groin and arm must allow access.
- Korábbi kezelés
- People cannot join if they had major surgery or a procedure inside the blood vessels within 30 days before surgery.
A részvétel fő kizáró okai
- Burst aneurysm with unstable blood pressure and circulation, aortic dissection (a tear in the artery wall), or an infected aneurysm
- Blocked gut or kidney arteries
- Heart attack or unstable angina within 6 months, or stroke or mini-stroke within 3 months
- ALT or AST ≥ 5 times the upper limit of normal, or serum creatinine ≥ 150 μmol/L (1,7 mg/dL)
- Pregnancy, planning pregnancy, or breastfeeding; connective tissue disease such as Marfan's syndrome; life expectancy less than 1 year
A regiszter feltételei, szó szerint
Mind a 25 feltétel megnézéseKevesebb
Ki vehet részt
- 18 years old ≤ age ≤ 80 years old
- Diagnosed as thoracoabdominal aortic aneurysm (based on modified Crawford classification and 2019 European Guidelines for the Treatment of Aortic aneurysm) and should meet at least one of the following conditions; Maximum diameter of thoracoabdominal aortic aneurysm>50mm; The diameter has increased by more than 5mm in recent 6 months or the by more than 10mm in recent 1 year
- anatomical criteria; The proximal anchoring region (aorta or implanted graft) was 17~36 mm in diameter and ≥25 mm in length; Distal anchoring region (aorta or implanted graft): If the distal anchoring region is in the iliac artery, the anchoring region has a diameter range of 7~25 mm and a length of ≥15 mm; If the distal anchoring area is in the abdominal aorta, the diameter of the anchoring area ranges from 12~36mm and the length≥ 20mm; The diameter of the vessel anchoring area of the visceral branch ranges from 6~13 mm and the length ≥15 mm; The diameter of renal artery anchoring area ranges from 4.5~9mm, and the length ≥15 mm; Appropriate iliac, femoral and upper limb artery access
- Patients who can understand the purpose of the trial, voluntarily participate and sign the informed consent, and are willing to complete the follow-up according to the requirements of the protocol
Ki nem vehet részt
- Undergone major surgical or interventionic surgery within 30 days before surgery
- Patients whose systemic or local infection may increase the risk of intravascular graft infection
- A history of acute coronary syndrome within 6 months; Acute coronary syndrome is defined as an acute ischemic syndrome of the heart resulting from the rupture or erosion of unstable intracoronary atherosclerotic plaques followed by fresh thrombosis, including ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, and unstable angina pectoris
- Transient ischemic attack (TIA) or ischemic/haemorrhagic stroke within 3 months
- Severe pulmonary insufficiency who cannot tolerate general anaesthesia
- A history of allergy to contrast agents, anticoagulants, antiplatelet drugs, stents, and conveyor materials (nitinol, polyester, PTFE, nylon)
- Connective tissue diseases such as systemic lupus erythematosus, Marfan's syndrome, Adam's syndrome, or Behcet's disease
- Serious vital organ dysfunction or other serious disease
- Preoperative liver renal function abnormalities (ALT or AST ≥ 5 times the upper limit of normal value), or serum creatinine ≥ 150 μmol/L
- Hemodynamically unstable patients with ruptured thoracoabdominal aortic aneurysms
- Thoracoabdominal aortic dissection
- Mycotic or infectious thoracoabdominal aortic aneurysm
- Superior mesenteric, celiac, or renal artery occlusion
- Requiring simultaneous coverage and embolization of bilateral internal iliac arteries
- Severe stenosis, calcification, or mural thrombus in the anchoring area of the stent tend to have difficulty in attachment of the stent-graft or affect the patency of the stent
- Severe coagulation dysfunction
- takayasu arteritis
- Planning pregnancy, pregnancy, or breastfeeding
- Patients who participated in other clinical trials and was not discontinued or withdrawn within the first 3 months of the screening period of this trial
- Life expectancy less than 1 year
- Patients who, in the judgment of the investigator, are not eligible for endotherapy
Nézd meg, megfelelhetsz-e
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 80 év között vagy?
Helyszínek itt: Kína
- Chinese PLA General HospitalBeijing, KínaContact: Wei GuoRésztvevőt keres
A vizsgálatról
Mit akar kideríteni a vizsgálat
Evaluation of the safety and efficacy of a multi-branched thoracoabdominal stent graft system for thoracoabdominal aortic aneurysm.
A vizsgálat csoportja
- Intervention armA vizsgált kezelés
Patients with thoracoabdominal aortic aneurysms, and passed the screening and signed the informed consent form.
Kezelés: Multi-Branched Thoracoabdominal Stent Graft System
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Guo's Renovisceral Artery Reconstruction-1: a Prospective, Multicenter, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of a Multi-branched Stent Graft System for Thoracoabdominal Aortic Aneurysm (GUARANTEE Study)
- MI-összefoglaló
- A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
- Illeszkedési kérdések
- Forrás: NCT05054985: ki vehet részt
- Publikációk
- A regiszteradat frissítve
- 2025. június 22.